← Open Payments lookup

KATHERINE BUKOLT: Open Payments

NPI 1538324272 · DALLAS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,300 in 25 payments from 12 companies in 2025. Trend: 2023 $1,781 · 2024 $1,064 · 2025 $1,300

Food & beverage: $1,300
CompanyPaymentsAmount
Takeda Pharmaceuticals U.S.A., Inc.3$230
ABBVIE INC.5$194
AstraZeneca Pharmaceuticals LP4$191
BeOne Medicines USA, Inc.1$143
Pharmacosmos Therapeutics Inc.1$134
Adaptive Biotechnologies Corporation1$123
Novartis Pharmaceuticals Corporation2$68
Bayer Healthcare Pharmaceuticals Inc.2$55
Daiichi Sankyo Inc.2$54
Merck Sharp & Dohme LLC2$52

Products named: FRUZAQLA, BRUKINSA, MONOFERRIC, clonoSEQ, PLUVICTO, IMFINZI, Enhertu, EPKINLY.

Industry payments across TX — which companies pay providers there.